Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 155 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Fountzilas, George  [Clear All Filters]
2014
Pectasides, E., Rampias T., Sasaki C., Perisanidis C., Kouloulias V., Burtness B., et al. (2014).  Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).. PLoS One. 9(4), e94273.
Pancoska, P., Kirkwood J. M., Bouros S., Spyropoulou-Vlachou M., Pectasides E., Tsoutsos D., et al. (2014).  A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon.. PLoS One. 9(1), e86375.
Koumarianou, A., Tzeveleki I., Mekras D., Eleftheraki A. G., Bobos M., Wirtz R., et al. (2014).  Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.. Anticancer Res. 34(9), 4949-62.
Psyrri, A., Kotoula V., Fountzilas E., Alexopoulou Z., Bobos M., Televantou D., et al. (2014).  Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer.. Oral Oncol. 50(4), 298-305.
Krikelis, D., Kotoula V., Bobos M., Fountzilas E., Markou K., Karasmanis I., et al. (2014).  Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.. Anticancer Res. 34(11), 6495-503.
Pentheroudakis, G., Kotoula V., Fountzilas E., Kouvatseas G., Basdanis G., Xanthakis I., et al. (2014).  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).. BMC Cancer. 14, 111.
2013
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Televantou, D., Karkavelas G., Hytiroglou P., Lampaki S., Iliadis G., Selviaridis P., et al. (2013).  DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.. Pathol Oncol Res. 19(2), 329-43.
Briasoulis, E., Aravantinos G., Kouvatseas G., Pappas P., Biziota E., Sainis I., et al. (2013).  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.. BMC Cancer. 13, 263.
Batistatou, A., Televantou D., Bobos M., Eleftheraki A. G., Kouvaras E., Chrisafi S., et al. (2013).  Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.. Anticancer Res. 33(5), 2139-45.
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Fountzilas, E., Kotoula V., Angouridakis N., Karasmanis I., Wirtz R. M., Eleftheraki A. G., et al. (2013).  Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.. PLoS One. 8(8), e70429.
Mountzios, G., Kostopoulos I., Kotoula V., Sfakianaki I., Fountzilas E., Markou K., et al. (2013).  Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer.. PLoS One. 8(1), e54048.
Fountzilas, G., Kotoula V., Pectasides D., Kouvatseas G., Timotheadou E., Bobos M., et al. (2013).  Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.. PLoS One. 8(7), e69256.
Bojesen, S. E., Pooley K. A., Johnatty S. E., Beesley J., Michailidou K., Tyrer J. P., et al. (2013).  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nat Genet. 45(4), 371-84, 384e1-2.
Pentheroudakis, G., Pavlidis N., Fountzilas G., Krikelis D., Goussia A., Stoyianni A., et al. (2013).  Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.. Mol Cancer. 12, 57.
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
Crown, J. P., Diéras V., Staroslawska E., Yardley D. A., Bachelot T., Davidson N., et al. (2013).  Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.. J Clin Oncol. 31(23), 2870-8.
Stavropoulou, A. V., Fostira F., Pertesi M., Tsitlaidou M., Voutsinas G. E., Triantafyllidou O., et al. (2013).  Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.. PLoS One. 8(3), e58182.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.
Pentheroudakis, G., Kotoula V., Eleftheraki A. G., Tsolaki E., Wirtz R. M., Kalogeras K. T., et al. (2013).  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).. PLoS One. 8(7), e70634.
Kamposioras, K., Konstantara A., Kotoula V., Lakis S., Kouvatseas G., Akriviadis E., et al. (2013).  The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.. Anticancer Res. 33(10), 4573-84.
Hyphantis, T., Papadimitriou I., Petrakis D., Fountzilas G., Repana D., Assimakopoulos K., et al. (2013).  Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.. Psychooncology. 22(9), 2009-15.
Meade, S., Sanghera P., McConkey C., Fowler J., Fountzilas G., Glaholm J., et al. (2013).  Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.. Int J Radiat Oncol Biol Phys. 86(1), 157-63.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές